702 related articles for article (PubMed ID: 24440221)
1. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
[TBL] [Abstract][Full Text] [Related]
2. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
[TBL] [Abstract][Full Text] [Related]
3. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
Regueiro M; Feagan BG; Zou B; Johanns J; Blank MA; Chevrier M; Plevy S; Popp J; Cornillie FJ; Lukas M; Danese S; Gionchetti P; Hanauer SB; Reinisch W; Sandborn WJ; Sorrentino D; Rutgeerts P;
Gastroenterology; 2016 Jun; 150(7):1568-1578. PubMed ID: 26946343
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
5. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K
Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
[TBL] [Abstract][Full Text] [Related]
6. Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.
Sorrentino D; Marino M; Dassopoulos T; Zarifi D; Del Bianco T
PLoS One; 2015; 10(12):e0144900. PubMed ID: 26670274
[TBL] [Abstract][Full Text] [Related]
7. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
[TBL] [Abstract][Full Text] [Related]
9. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease.
Sorrentino D; Paviotti A; Terrosu G; Avellini C; Geraci M; Zarifi D
Clin Gastroenterol Hepatol; 2010 Jul; 8(7):591-9.e1; quiz e78-9. PubMed ID: 20139033
[TBL] [Abstract][Full Text] [Related]
10. Infliximab for the treatment of fistulas in patients with Crohn's disease.
Present DH; Rutgeerts P; Targan S; Hanauer SB; Mayer L; van Hogezand RA; Podolsky DK; Sands BE; Braakman T; DeWoody KL; Schaible TF; van Deventer SJ
N Engl J Med; 1999 May; 340(18):1398-405. PubMed ID: 10228190
[TBL] [Abstract][Full Text] [Related]
11. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.
Fedorak RN; Feagan BG; Hotte N; Leddin D; Dieleman LA; Petrunia DM; Enns R; Bitton A; Chiba N; Paré P; Rostom A; Marshall J; Depew W; Bernstein CN; Panaccione R; Aumais G; Steinhart AH; Cockeram A; Bailey RJ; Gionchetti P; Wong C; Madsen K
Clin Gastroenterol Hepatol; 2015 May; 13(5):928-35.e2. PubMed ID: 25460016
[TBL] [Abstract][Full Text] [Related]
12. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.
Mowat C; Arnott I; Cahill A; Smith M; Ahmad T; Subramanian S; Travis S; Morris J; Hamlin J; Dhar A; Nwokolo C; Edwards C; Creed T; Bloom S; Yousif M; Thomas L; Campbell S; Lewis SJ; Sebastian S; Sen S; Lal S; Hawkey C; Murray C; Cummings F; Goh J; Lindsay JO; Arebi N; Potts L; McKinley AJ; Thomson JM; Todd JA; Collie M; Dunlop MG; Mowat A; Gaya DR; Winter J; Naismith GD; Ennis H; Keerie C; Lewis S; Prescott RJ; Kennedy NA; Satsangi J;
Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):273-282. PubMed ID: 28404197
[TBL] [Abstract][Full Text] [Related]
13. Strategies for the prevention of postoperative recurrence of Crohn's disease.
Yamamoto T; Watanabe T
Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission.
Papamichael K; Vande Casteele N; Gils A; Tops S; Hauenstein S; Singh S; Princen F; Van Assche G; Rutgeerts P; Vermeire S; Ferrante M
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1103-10. PubMed ID: 25478919
[TBL] [Abstract][Full Text] [Related]
15. Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in Japan.
Fukushima K; Sugita A; Futami K; Takahashi KI; Motoya S; Kimura H; Yoshikawa S; Kinouchi Y; Iijima H; Endo K; Hibi T; Watanabe M; Sasaki I; Suzuki Y;
Surg Today; 2018 Jun; 48(6):584-590. PubMed ID: 29383596
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.
Louis E; Mary JY; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Dupas JL; Pillant H; Picon L; Veyrac M; Flamant M; Savoye G; Jian R; Devos M; Porcher R; Paintaud G; Piver E; Colombel JF; Lemann M;
Gastroenterology; 2012 Jan; 142(1):63-70.e5; quiz e31. PubMed ID: 21945953
[TBL] [Abstract][Full Text] [Related]
17. Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients.
Olbjørn C; Nakstad B; Småstuen MC; Thiis-Evensen E; Vatn MH; Perminow G
Scand J Gastroenterol; 2014 Dec; 49(12):1425-31. PubMed ID: 25310799
[TBL] [Abstract][Full Text] [Related]
18. Postoperative infliximab is not associated with an increase in adverse events in Crohn's disease.
Regueiro M; El-Hachem S; Kip KE; Schraut W; Baidoo L; Watson A; Swoger J; Schwartz M; Barrie A; Pesci M; Binion D
Dig Dis Sci; 2011 Dec; 56(12):3610-5. PubMed ID: 21681507
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
[TBL] [Abstract][Full Text] [Related]
20. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
